
18-Month Study: Aveed’s Impact on Lipid Profiles and Insulin Sensitivity in Hypogonadal Men
Reading Time: 2 minutes Introduction Aveed, a testosterone undecanoate injection developed by Endo Pharmaceuticals, has been widely utilized for the treatment of hypogonadism in American males. Given the pivotal role of testosterone in metabolic regulation, understanding the long-term effects of Aveed on key metabolic parameters such as lipid profiles and insulin sensitivity is crucial. This article delves into a comprehensive 18-month study assessing these effects, providing valuable insights for clinicians and patients alike. Study Design and Methodology The study involved a cohort of 250 American males diagnosed with hypogonadism, aged between 30 and 65 years. Participants were administered Aveed at standard intervals over 18...